Kidney Cancer DNA Registry

ConditionRenal Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorMemorial Sloan Kettering Cancer Center

About this trial

This registry will help us develop better methods of:

* Preventing these cancers * Diagnosing these cancers * Treating these cancers

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Must be ≥ 18 years of age AND

Must be an English-speaker AND

Must have a diagnosis or suspicion of kidney cancer

Must be ≥ 18 years of age AND

Disqualifiers

Patients who, in the opinion of the primary MSKCC clinician or the investigator, have a condition that precludes their ability to provide an informed consent

Trial population

Urologists, clinical geneticists, and medical oncologists at MSKCC, along with study personnel will identify patients, family members, and unaffected controls that may be eligible for the registry. Patients and families may also be directly referred to the MSKCC study team by any MSKCC physician, external physician, or by the family itself.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

salvia for germline DNA
Other intervention
the Kidney Cancer Questionnaire
Behavioral
Patients will complete the appropriate surveys on either paper or on the computer/iPad in the office using REDCap software. If patients are unable to complete their questionnaires at the time of their in-office visit, a link to the questionnaires in REDCap will be emailed to them. The survey data that is collected in REDCap will be stored in REDCap. Clinic staff may also call patients to remind patients to complete questionnaires.
Family History Questionnaire (when applicable)
Behavioral
Patients will complete the appropriate surveys on either paper or on the computer/iPad in the office using REDCap software. If patients are unable to complete their questionnaires at the time of their in-office visit, a link to the questionnaires in REDCap will be emailed to them. The survey data that is collected in REDCap will be stored in REDCap. Clinic staff may also call patients to remind patients to complete questionnaires.
Blood draw
Other intervention
Epidemiologic Questionnaire
Behavioral
Patients will complete the appropriate surveys on either paper or on the computer/iPad in the office using REDCap software. If patients are unable to complete their questionnaires at the time of their in-office visit, a link to the questionnaires in REDCap will be emailed to them. The survey data that is collected in REDCap will be stored in REDCap. Clinic staff may also call patients to remind patients to complete questionnaires.

Treatment groups

750 Participants

are divided into 4 treatment groups

Group A: kidney cancer patients receiving care at MSKCC5 interventions

Group B: relatives of patients with kidney cancer3 interventions

Group C: healthy controls who are unrelated & do not have hx of cancer3 interventions

Group D: high risk4 interventions

Trial outcomes

Primary outcomes

establish a kidney cancer registry

with detailed epidemiologic data and germline DNA available for next generation sequencing from consenting patients, selected family members, and healthy unrelated controls.

Time frame

5 years

Locations7

Select a site below to view it on the map.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Memorial Sloan Kettering Cancer Center

Lead sponsor

Source ClinicalTrials.gov

Apply now